Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Teijin starts clinical trials of in-licensed antiasthmatic drug

Dec. 24, 1997

Boehringer Ingelheim to develop and market Procysteine in Japan

Dec. 24, 1997

Jouveinal patents PDE IV inhibitors

Dec. 24, 1997

HNE inhibitors prepared at Glaxo Wellcome

Dec. 24, 1997

Neurokinin antagonists in the pipeline at Schering-Plough

Dec. 23, 1997

Schering-Plough obtains rights to Claritin metabolite from Sepracor

Dec. 22, 1997

Vyrex's respiratory antioxidant shows potential as asthma therapy

Dec. 22, 1997

Patient enrollment completed for ARDS phase Ib trial

Dec. 18, 1997

Singulair available in Mexico for asthma

Dec. 17, 1997

Atopy associated with IL-4R mutation; findings support Immunex's development of soluble IL-4R

Dec. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...